Quantum-Si (QSIAW)
0.34
-0.02 (-6.72%)
At close: Apr 17, 2025, 3:59 PM
0.34
0.00%
After-hours: Apr 17, 2025, 04:00 PM EDT
Company Description
Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS).
The company's platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; and reagent kits and semiconductor chips for use with its instruments.
It is used in protein identification, protein variants, antibody characterization, biomarker identification, and post translational modification analysis applications.
The company was founded in 2013 is headquartered in Branford, Connecticut.
Quantum-Si
| Country | United States |
| IPO Date | n/a |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 149 |
| CEO | Jeffrey Alan Hawkins |
Contact Details
Address: 29 Business Park Drive Branford, Delaware United States | |
| Website | https://www.quantum-si.com |
Stock Details
| Ticker Symbol | QSIAW |
| Exchange | NASDAQ |
| Fiscal Year | n/a |
| Reporting Currency | USD |
| CIK Code | 0001816431 |
| CUSIP Number | 74765K113 |
| ISIN Number | US74765K1135 |
| Employer ID | 85-1388175 |
| SIC Code | 3829 |
Key Executives
| Name | Position |
|---|---|
| Jeffrey Alan Hawkins | President, Chief Executive Officer & Director |
| Jeffry R. Keyes CPA | Chief Financial Officer & Treasurer |
| Todd Rearick | Chief Technology Officer |
| Dr. Christian Lapointe J.D., Ph.D. | General Counsel & Corporate Secretary |
| Dr. John S. Vieceli Ph.D. | Chief Product Officer |
| Dr. Jonathan M. Rothberg Ph.D. | Founder & Executive Director |
| Katherine Atkinson | Senior Vice President of Demand Generation & Corporate Brand |
| Lindsay Thompson | Chief Human Resources Officer |
| Todd C. Bennett | Chief Commercial Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 10, 2025 | 8-K | Current Report |
| Mar 24, 2025 | 4 | Filing |
| Mar 24, 2025 | 4 | Filing |
| Mar 24, 2025 | 4 | Filing |
| Mar 24, 2025 | 4 | Filing |
| Mar 20, 2025 | ARS | Filing |
| Mar 20, 2025 | DEFA14A | Filing |
| Mar 20, 2025 | DEF 14A | Filing |
| Mar 14, 2025 | 4 | Filing |
| Mar 14, 2025 | 4 | Filing |